Dr Marietjie Botes
Co-Author – Human Biological Material (Lawsa Volume 26(1) – Third Edition)
Dr Marietjie Botes holds BProc, LLB, LLM and LLD degrees.
She exchanged a 20-year career as an attorney practising and specialising in the intersection between law, science and technology in the fields of Health-tech, Fin-tech and Biotech, for academia in 2019. She joined the Health Law and Bioethics group of the University of Kwa-Zulu Natal as a senior postdoctoral researcher and focused on genetic research regulation, privacy issues relating to health information, data sharing and related intellectual property rights, gene editing and stem cell therapy, whilst lecturing Medical Law, Human Rights and Ethical Theories at the School of Health Sciences.
Since the COVID-19 outbreak Dr Botes has become actively involved in pandemic preparedness and management research, writing the section about the pandemic’s impact on human rights in the Country Report on governmental leadership, governance and the implementation of measures to combat COVID-19 in South Africa. Dr Botes is also serving on the panel of experts of the Academy of Sciences of South Africa (ASSAf) to investigate, advise and write consensus reports on the Ethical, Legal and Social Issues (ELSI) related to Advanced Therapies such as gene therapy and stem cell research. She also serves on the Network of African Science Academies (NASAC) and Africa Harvest’s Gene Editing Technology Initiative (GETI) working group.
In April 2021 she joined a Research Group at the Interdisciplinary Centre for Security, Reliability and Trust at the University of Luxembourg as a Researcher investigating the intersection between science, technology, and law.